Topic - Adamis Pharmaceuticals Corp.

Related Stories

This photo provided by Adamis Pharmaceuticals Corp. shows the Symjepi syringe, prefilled with the hormone epinephrine, which helps stop life-threatening allergic reactions from insect stings and bites or eating foods such as nuts and eggs. On Thursday, June 15, 2017, the Food and Drug Administration approved the Adamis Pharmaceuticals Corp. product, which is expected to go on sale later in 2017. (Audacity Health/Courtesy of Adamis Pharmaceuticals Corp. via AP)

FDA approves new, cheaper rival to EpiPen allergy shot

By LINDA A. JOHNSON - Associated Press

Business Highlights

By The Associated Press - Associated Press